Related Experiment Videos
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin.
Journal of the American Academy of Dermatology·2001
A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne.
Journal of the American Academy of Dermatology·2001
The relationship between biopsy technique and uncertainty in the histopathologic diagnosis of melanoma.
Dermatology online journal·2000
A double-blind, placebo-controlled study of topical tetracaine in the treatment of herpes labialis.
Journal of the American Academy of Dermatology·1999
Benign neoplasms of the skin.
The Medical clinics of North America·1999
Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.
Journal of the American Academy of Dermatology·1998
Comparison of Early and Late Latent Syphilis- Colorado, 1991.
Archives of dermatology·2016
Case of Rhinoscleroma.
Archives of dermatology·2016
Cutaneous Fungal Infections.
Archives of dermatology·2016
An Ulcerated Plaque in a Gay Man.
Archives of dermatology·2016
Solitary Violaceous Nodule on the Face.
Archives of dermatology·2016
Erythematous Plaques on the Eyelids.
Archives of dermatology·2016
The impact of HIV co-infection on presentation and outcome in adults with tuberculous pericarditis: Findings from the IMPI trial.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
Targeting IMPDH2 by Casticin attenuates psoriatic inflammation by suppressing STAT3 activation in keratinocytes.
International immunopharmacology·2026
IGFBP2 Knockdown Ameliorates Diabetic Gastroparesis by Inhibiting VDAC1-Dependent Mitophagy in Interstitial Cells of Cajal.
Endocrine, metabolic & immune disorders drug targets·2026